Reducing uncertainty in the derivation and application of health guidance values in public health practice. Dioxin as a case study

Annals of the New York Academy of Sciences

Volumn 895, Issue , 1999, Pages 348-364

  De Rosa, Christopher T ^a   Pohl, Hana R ^a   Hansen, Hugh ^a   Leonard, Robin C ^b   Holler, James ^a   Jones, Dennis ^a  

^a AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

^b DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL COMPOUND; DIOXIN; ENVIRONMENTAL CHEMICAL; TOXIC SUBSTANCE;

BODY BURDEN; CHEMICAL INTERACTION; CONFERENCE PAPER; DANGEROUS GOODS; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL PROTECTION; GOOD CLINICAL PRACTICE; HUMAN; PUBLIC HEALTH SERVICE; REGISTER; RISK ASSESSMENT; SOIL POLLUTANT; STATISTICAL PARAMETERS; TOXICOKINETICS; TOXICOLOGY;

EID: 0033403867     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08095.x     Document Type: Conference Paper

References (45)

1. 1. De Rosa, C.T., H. Pohl, M. Williams, A. Ademoyero, S. Chou & D. Jones. 1998. Public health implications of environmental exposures. Environ. Health Perspect. 106 (Suppl.1): 369-378.
2. 2. Pohl, H.R. & H.G. Abadin. 1995. Utilizing uncertainty factors in minimal risk levels derivation. Regulat. Toxicol. Pharmacol. 22: 180-188.
3. 3. De Rosa, C.T., D. Brown, R. Dhara, W. Garrett, H. Hansen, J. Holler, D. Jones, D. Jordan-Izaguirre, R. O'Connor, H. Pohl & C. Xintaras. 1997. Dioxin and dioxin-like compounds in soil, part I: ATSDR interim policy guideline. Toxicol. Ind. Health 13(6): 759-768.
4. 4. De Rosa, C.T., D. Brown, R. Dhara, W. Garrett, H. Hansen, J. Holler, D. Jones, D. Jordan-Izaguirre, R. O'Connor, H. Pohl, C. Xintaras. 1997. Dioxin and dioxin-like compounds in soil, pari II: Technical support document for ATSDR interim policy guideline.Toxicol. Ind. Health 13(6): 769-804.
5. 5. Agency for Toxic Substances and Disease Registry (ATSDR). 1997. Toxicological profile for chlorinated dibenzo-p-dioxins. U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry, Atlanta.
6. 6. Agency for Toxic Substances and Disease Registry (ATSDR). 1995. Guidance for developing texicological profiles. U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry, Atlanta.
7. 7. Bowman, R.E., S.L. Schantz, M.L. Gross et al. 1989. Behavioral effects in monkeys exposed to 2,3,7,8-TCDD transmitted maternally during gestation and for four months of nursing. Chemosphcrc 18: 235-242.
8. 8. Schantz, S.L. & R.E. Bowman. 1989. Learning in monkeys exposed perinatally to 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD). Neurotoxicol. Teratol. 11: 13-19.
9. 9. Schantz, S.L., S.A. Ferguson & RE. Bowman 1992. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on behavior of monkey in peer groups. Neurotoxicol. Teratol. 14: 433-446.
10. 10. Rier, S.E., D.C. Martin & RE. Bowman et al. 1993. Endometriosis in Rhesus monkeys following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fund. Appl. Toxicol. 21: 433-441.
11. 11. Wheeler, J.M. 1992. Epidemiology and prevalences of endomelriosis. Infertil. Reprod. Med. Clin. N.A. 3: 545-549.
12. 12. Boyd, J.A., G.C. Clark, D.K. Walmer et al. 1995. Endometriosis and the environment biomarkers of toxin exposure. Abslract of Endomelriosis 2000 Workshop, May 15-17.
13. 13. U.S. Environmental protection Agency (EPA). 1997. Special report on environmental endocrine disruption: An effects assessment and analysis. Risk Assessment Forum. U.S. Environmental Protection Agency, Washington DC. EPA/630/R-96/ 012.
14. 14. Agency for Toxic Substances and Disease Registry (ATSDR). 1996. Minimal risk levels for priority substances and guidance for derivation. Federal Register 61(101): 25873-25882.
15. 15. Dourson, M.L. & J.F. Stara. 1983. Regulatory history and experimental support of uncertainty (safety) factors. Regul. Toxicol. Pharmacol. 3: 224-238.
16. 16. U.S. Environmental protection Agency (EPA). 1989. General quantitative risk assessment guidelines for noncancer health effects (draft). U.S. Environmental Protection Agency, Washington DC. ECAO-CIN-538.
17. 17. Calabrese, E.J. 1985. Uncertainty factors and interindividual variation Regul. Toxicol. Pharmacol. 5: 190-196.
18. 18. Fries, G.F. & G.S. Marrow. 1975. Retention and excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin by rats. J. Agric. Food Chem. 23: 265-269.
19. 19. Piper, W.N., R.Q. Rose & P.J. Gehring 1973. Excretion and tissue distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. Environ. Health Perspect. 5: 241-244.
20. 20. Rose, J.Q., J.C. Ramsey, T.H. Wentzler et al. 1976. The fate of 2,3,7,8-tetrachlorodibenzo-p-dioxin following single and repeated oral doses to the rat. Toxicol. Appl. Pharmacol. 36: 209-226.
21. 21. Agency for Toxic Substances and Disease Registry (ATSDR). 1989. Toxicological profile for 2,3,7,8-tetrachlorodibenzo-p-dioxin. U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry, Atlanta.
22. 22. Murray, F.J., F.A. Smith, K.D. Nitschke, C.G. Humiston, R.J. Kociba & B.A. Schwetz. 1979. Three-generation reproduction study of rats given 2,3,7,8-tetrachlorodibenzo-p-dioxin isomers using a polymeric liquid crystal capillary column. J. Chromatogr. 369(1): 203-207.
23. 23. Allen, J.R., D.A. Barsotti, L.K. Lambrecht et al. 1979. Reproductive effects of halogenatcd aromatic hydrocarbons on nonhuman primates. Ann. N.Y. Acad. Sci. 320: 419-425.
24. 24. Johnson, B.L., H.E. Hicks, D.E. Jones, W. Cibulas, A. Wargo & C.T. De Rosa. 1998. Public health implications of persistent toxic substances in the Great Lakes and St. Lawrence Basins. J. Great Lakes Research. 24(2): 698-722.
25. 25. Turner, J.N. & D.N. Collins. 1983. Liver morphology in guinea pigs administered either pyrolysis products of a polychlorinated biphenyl transformer fluid or 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 67: 417-429.
26. 26. Burleson, G.R., H. Lebrec, Y.G. Yang et al. 1996. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza virus host resistance in mice. Fund. Appl. Toxicol. 29: 40-47.
27. 27. Agency for Toxic Substances and Disease Registry (ATSDR). 1992. Public health assessment guidance manual. U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry, Atlanta. NTIS PB92-147164.
28. 28. Binder, S., D. Sokal & D. Maughn. 1986. The use of tracer elements in estimating the amount of soil ingested by young children. Arch. Environ. Health 41: 341-345.
29. 29. Clausing, P., B. Brunekrefe & J.H. Van Wijen. 1987. A method for estimating soil ingestion by children. Int. Arch. Occup. Environ. Health 59: 73-82.
30. 30. Kimbrough, R.D., H. Falk, P. Stehr et al. 1984. Health implications of 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) contamination of residential soil. J. Toxicol. Environ. Health 14: 47-93.
31. 31. Gough, M. 1991. Human exposures from dioxin in soil - a meeting report. J. Toxicol. Environ. Health 32: 205-245.
32. 32. U.S. Environmental protection Agency (EPA). 1989. Exposure Factors Handbook. U.S. Environmental Protection Agency, Office of Health and Environmental Assessment, Washington, DC. EPA/600/8-89/043. July 1989.
33. 33. Poiger, H. & C. Schlatter. 1986. Pharmacokinetics of 2,3,7,8-TCDD in man. Chemosphere 15: 1489-1494.
34. 34. Umbreit, T.H., E.J. Hesse & M.A. Gallo. 1986. Bioavailability of dioxin in soil from a 2,4,5-T manufacturing site. Science 232: 497-499.
35. 35. Umbreit, T.H., E.J. Hesse & M.A. Gallo. 1986. Comparative toxicity of 2,3,7,8-TCDD contaminated soil from Times Beach, Missouri, and Newark, New Jersey. Chemosphere 15: 2121-2124.
36. 36. Lucier, G.W., R.C. Rumbaugh, Z. McCoy et al. 1986. Ingestion of soil contaminated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) alters hepatic enzyme activities in rats. Fundam. Appl. Toxicol. 6: 364-371.
37. 37. McConnell, E.E., G.W. Lucier, R.C. Rumbaugh et al. 1984. Dioxin in soil: bioavailability after ingestion by rats and guinea pigs. Science 223: 1077-1079.
38. 38. Pohl, H., C.T. De Rosa & J. Holler. 1995. Public health assessment for dioxins exposure from soil. Chemosphere 31(1): 2437-2454.
39. 39. Paustenbach, D.J., H.P. Shu & F.J. Murray. 1986. A critical examination of assumptions used in risk assessments of dioxin contaminated soil. Regul. Toxicol. Pharmacol. 6: 284-307.
40. 40. World Health Organization (WHO). 1991. Consultation on tolerable daily intake from food of PCDDs and PCDFs. Summary Report. World Health Organization, Bilthoven, the Netherlands.
41. 41. Nestrick, T.J., L.L. Lamparski, M.N. Frawley et al. 1986. Perspectives of a large scale environmental survey for chlorinated dioxins: overview and soil data. Chemosphere 15: 1453-1460.
42. 42. Schierow, L.J. 1995. Dioxin: reassessing the risk. CRS Report to Congress. Environment and Natural Resources Policy Division.
43. 43. U.S. Environmental protection Agency (EPA). 1989. Interim procedures for estimating risks associated with exposure to mixtures of chlorinated dibenzo-p-dioxins and dibenzofurans (CDDs and CDFs) and 1989 update. U.S. Environmental Protection Agency, Risk Assessment Forum. EPA 625/3-89/016. NTIS PB90-145756.
44. 44. U.S. Environmental protection Agency (EPA). 1987. The risk assessment guidelines of 1986. U.S. Environmental Protection Agency, Office of Health and Environmental Assessment. EPA/600/8-87/045.
45. 45. Van den Berg, M., L. Birnbaum & A.T.C. Bosveld. 1998. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ. Health Perspect. 106(12): 775-792.